EPO levels were found to be lower in patients with GAD, and the sensitivity and specificity of serum EPO levels were found to be 100% and 85.9%, respectively, based on a cut-off point of 6.11 mlU/mol (AUC: 0.901) (Kurutas 2023). Here, EPO is linked to generalized anxiety disorder.